ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 619860 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 619860; 2) Community: the network communities that were significantly associated with the response to NSC 619860; 3) Molecule: the relationships between components within communities and NSC 619860; 4) MDR: the compounds that were significantly associated with the NSC 619860.

NSC Compound Enrichment Correlation
NSC 676532 Ether-20 0.0474314077111082 0.012584234
NSC 681972 Null 0.0474314077111082 -0.06229656
NSC 697535 Null 0.0474314077111082 -0.099222028
NSC 700862 4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- 0.0474314077111082 0.28466833
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.0474314077111082 0.26273079
NSC 720134 Null 0.0474314077111082 -0.42701275
NSC 726217 Combretastatin A4-analogue 0.0474314077111082 -0.01746909
NSC 726578 Null 0.0474314077111082 0.2754433
NSC 730009 cis-2,5,6,12,13-Pentahydro-6-methyl-(8,9-methylenedioxy)-3-n itro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0474314077111082 0.20221598
NSC 732936 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0474314077111082 0.14053898
Total:76  Current:71    [First] [Prev] [Next] [Last]